VOYA Investment Management
INBX icon

VOYA Investment Management’s Inhibrx INBX Stock Holding History

VOYA Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,512
Closed -$371K – 2523
2026
Q1 		$371K Sell
5,512
-52
-0.9% -$3.86K ﹤0.01% 1860
2025
Q4 		$440K Buy
+5,564
New +$379K ﹤0.01% 1809

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's INBX Position: Q2 2026 in Review

VOYA Investment Management sold out of Inhibrx (INBX) in Q2 2026, closing a stake of 5,512 shares — an estimated $371K sold.

VOYA Investment Management first reported a position in INBX in Q4 2025 and held it in 2 quarters. The position peaked at $440K in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • VOYA Investment Management reported no remaining Inhibrx position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 5,512 Inhibrx shares in Q2 2026, an estimated $371K.
  • VOYA Investment Management first reported a position in Inhibrx in Q4 2025 and held it in 2 quarters.
  • VOYA Investment Management's Inhibrx position peaked at $440K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.